4A3-SC8 SORT LNP lipid mixtures
Stock-volume recipes for base 4A3-SC8 mDLNP and the reported DODAP liver, DOTAP lung and 18PA spleen SORT alternatives.
Applicable scenario
Research formulations reported for 4A3-SC8-based mRNA LNPs and the source's liver-, lung- or spleen-targeted SORT experiments. Select exactly one alternative. Organ-targeting labels describe the cited research models, not a prediction for another payload, species or clinical use.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
Base 4A3-SC8 mDLNP
| Component | Stock concentration | Volume (µL) |
|---|---|---|
| 4A3-SC8 | 150 mg/mL | 6.7 |
| DOPE | 10 mg/mL | 50.7 |
| Cholesterol | 10 mg/mL | 52.7 |
| DMG-PEG | 10 mg/mL | 34.2 |
| Total lipid mixture | Base 4A3-SC8 mDLNP | 144.3 |
20% DODAP 4A3-SC8 liver SORT LNP
| Component | Stock concentration | Volume (µL) |
|---|---|---|
| 4A3-SC8 | 150 mg/mL | 6.7 |
| DOPE | 10 mg/mL | 50.7 |
| Cholesterol | 10 mg/mL | 52.7 |
| DMG-PEG | 10 mg/mL | 34.2 |
| DODAP | 32.4 mg/mL | 14.3 |
| Total lipid mixture | 20% DODAP liver SORT | 158.6 |
50% DOTAP 4A3-SC8 lung SORT LNP
| Component | Stock concentration | Volume (µL) |
|---|---|---|
| 4A3-SC8 | 150 mg/mL | 6.7 |
| DOPE | 10 mg/mL | 50.7 |
| Cholesterol | 10 mg/mL | 52.7 |
| DMG-PEG | 10 mg/mL | 34.2 |
| DOTAP | 50 mg/mL | 40.0 |
| Total lipid mixture | 50% DOTAP lung SORT | 184.3 |
10% 18PA 4A3-SC8 spleen SORT LNP
| Component | Stock concentration | Volume (µL) |
|---|---|---|
| 4A3-SC8 | 150 mg/mL | 6.7 |
| DOPE | 10 mg/mL | 50.7 |
| Cholesterol | 10 mg/mL | 52.7 |
| DMG-PEG | 10 mg/mL | 34.2 |
| 18PA | 18.1 mg/mL in THF/ethanol (1:1) | 12.7 |
| Total lipid mixture | 10% 18PA spleen SORT | 157.0 |
Source values and calculations
- All stock concentrations and volumes are reported directly in the source; totals are arithmetic sums of the listed volumes.
- 4A3-SC8 stock is 150 mg/mL, DODAP is 32.4 mg/mL, DOTAP is 50 mg/mL and 18PA is 18.1 mg/mL in THF/ethanol (1:1 vol/vol). DOPE, cholesterol and DMG-PEG stocks are each 10 mg/mL.
- The four alternatives are mutually exclusive formulations, not sequential additions.
Literature source
Wang X et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nature Protocols 18, 265–291 (2023).
Source locator: Procedure, 4A3-SC8 lipid stock and complete lipid-mix preparation, p. 7 in the extracted article PDF
Read the original source · DOI: 10.1038/s41596-022-00755-x
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.